Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
23,900,548
-
Share change
-
+1,118,690
-
Total reported value
-
$331,501,291
-
Price per share
-
$13.87
-
Number of holders
-
52
-
Value change
-
+$9,453,144
-
Number of buys
-
24
-
Number of sells
-
25
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q1 2019
As of 31 Mar 2019,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,900,548 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, GOLDMAN SACHS GROUP INC, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Artal Group S.A., FMR LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, and HSBC HOLDINGS PLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.